Loading...
XJPX
4554
Market cap299mUSD
Jul 10, Last price  
1,894.00JPY
1D
1.72%
1Q
-23.13%
Jan 2017
40.30%
Name

Fuji Pharma Co Ltd

Chart & Performance

D1W1MN
XJPX:4554 chart
P/E
16.49
P/S
0.96
EPS
114.86
Div Yield, %
2.44%
Shrs. gr., 5y
-4.77%
Rev. gr., 5y
8.87%
Revenues
51.68b
+12.01%
11,240,000,00013,250,000,00014,937,000,00017,198,775,00019,698,482,00021,623,813,00021,520,418,00025,174,000,00029,215,000,00031,680,000,00034,229,000,00035,387,000,00037,909,000,00036,279,000,00033,793,000,00033,990,000,00035,426,000,00040,889,000,00046,138,000,00051,677,000,000
Net income
3.00b
-51.20%
915,000,0001,193,000,0001,251,000,0001,525,958,0001,944,071,0002,204,846,0001,370,930,0002,068,000,0002,078,000,0002,092,000,0002,118,000,0003,301,000,0003,372,000,0002,962,000,0002,085,000,0002,432,000,0002,697,000,0003,435,000,0006,147,000,0003,000,000,000
CFO
5.80b
+39.75%
1,637,000,0001,658,000,000952,631,0001,816,744,0002,168,237,0001,954,075,0001,171,679,0003,630,000,0002,757,000,000589,000,0004,509,000,0003,238,000,0003,773,000,0007,035,000,0005,770,000,0005,993,000,000-658,000,0001,917,000,0004,151,000,0005,801,000,000
Dividend
Sep 29, 202626 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
IPO date
Jun 22, 1995
Employees
1,560
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT